Nobel Prize Honors Pioneering Body's Defenses Research

This year's prestigious award in medical science has been awarded for transformative discoveries that clarify how the immune system targets harmful infections while sparing the body's own cells.

Three renowned scientists—from Japan Shimon Sakaguchi and American scientists Dr. Brunkow and Fred Ramsdell—received this accolade.

The work identified specialized "security guards" within the defense system that remove malfunctioning immune cells capable of harming the organism.

These findings are now paving the way for new treatments for autoimmune diseases and cancer.

These laureates will share a monetary award worth 11 million Swedish kronor.

Crucial Discoveries

"Their research has been decisive for understanding how the body's defenses functions and why we do not all suffer from serious self-attack conditions," commented the head of the award panel.

The trio's studies address a core question: In what way does the defense system protect us from countless invaders while leaving our own tissues unharmed?

The immune system employs immune cells that scan for indicators of disease, including pathogens and bacteria it has not met before.

These defenders employ detectors—known as receptors—that are generated by chance in a vast number of variations.

This provides the defense network the ability to combat a wide array of threats, but the unpredictability of the mechanism inevitably creates white blood cells that can target the host.

Security Guards of the Body

Researchers previously understood that a portion of these problematic defense cells were eliminated in the immune organ—the site where immune cells mature.

The latest Nobel Prize recognizes the discovery of T-reg cells—known as the immune system's "peacekeepers"—which travel through the body to neutralize any defenders that attack the body's own tissues.

We know that this mechanism malfunctions in self-attack conditions such as type-1 diabetes, multiple sclerosis, and RA.

A prize committee added, "These discoveries have established a new field of research and spurred the development of innovative therapies, for instance for cancer and autoimmune diseases."

In cancer, T-regs block the body from attacking the tumor, so studies are aimed at lowering their quantity.

In autoimmune diseases, experiments are exploring boosting regulatory T-cells so the body is not being harmed. A similar method could also be effective in reducing the chances of organ transplant failure.

Pioneering Studies

Professor Shimon Sakaguchi, from a Japanese institution, conducted tests on mice that had their thymus removed, leading to self-attack conditions.

He demonstrated that introducing immune cells from healthy mice could stop the disease—suggesting there was a mechanism for preventing defenders from harming the body.

Mary Brunkow, affiliated with the a research center in Seattle, and Fred Ramsdell, currently at a biotech firm in a California city, were studying an inherited immune disorder in mice and people that resulted in the identification of a genetic factor critical for how regulatory T-cells function.

"Their groundbreaking work has uncovered how the body's defenses is kept in check by regulatory T cells, preventing it from mistakenly attacking the body's own tissues," said a leading physiology specialist.

"The work is a remarkable illustration of how basic biological research can have broad implications for human health."